SE448344B - Antikropp for behandling av reumatoid artrit samt sett att framstella denna - Google Patents
Antikropp for behandling av reumatoid artrit samt sett att framstella dennaInfo
- Publication number
- SE448344B SE448344B SE7900798A SE7900798A SE448344B SE 448344 B SE448344 B SE 448344B SE 7900798 A SE7900798 A SE 7900798A SE 7900798 A SE7900798 A SE 7900798A SE 448344 B SE448344 B SE 448344B
- Authority
- SE
- Sweden
- Prior art keywords
- milk
- antibody
- bacteria
- immune
- bacterial
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0266—Klebsiella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0283—Shigella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/085—Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/104—Pseudomonadales, e.g. Pseudomonas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87514078A | 1978-02-06 | 1978-02-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
SE7900798L SE7900798L (sv) | 1979-08-07 |
SE448344B true SE448344B (sv) | 1987-02-16 |
Family
ID=25365266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7900798A SE448344B (sv) | 1978-02-06 | 1979-01-30 | Antikropp for behandling av reumatoid artrit samt sett att framstella denna |
Country Status (10)
Country | Link |
---|---|
JP (1) | JPS54113425A (it) |
CH (1) | CH651210A5 (it) |
DE (1) | DE2904044C2 (it) |
DK (1) | DK158138C (it) |
FR (1) | FR2416015A1 (it) |
GB (1) | GB2013691B (it) |
HK (1) | HK30283A (it) |
IT (1) | IT1116524B (it) |
NL (1) | NL7900766A (it) |
SE (1) | SE448344B (it) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE33565E (en) * | 1978-02-06 | 1991-04-02 | Stolle Research And Development Corporation | Prevention and treatment of rheumatioid arthritis |
US4732757A (en) * | 1978-02-06 | 1988-03-22 | Stolle Research And Development Corporation | Prevention and treatment of rheumatoid arthritis |
ATE14269T1 (de) * | 1981-02-26 | 1985-08-15 | Unilever Nv | Verfahren und vorrichtung zur rueckgewinnung von immunoglobulinen. |
EP0064103B1 (en) * | 1981-04-28 | 1985-11-06 | The Stolle Research And Development Corporation | Method of obtaining an anti-inflammatory bovine milk |
JP2561234B2 (ja) * | 1981-05-12 | 1996-12-04 | スト−ル・リサ−チ・アンド・デイベロップメント・コ−ポレ−ション | 抗炎症剤 |
JPS58154513A (ja) * | 1982-03-09 | 1983-09-14 | Sendai Biseibutsu Kenkyusho | 予防及び治療薬 |
US4636384A (en) * | 1982-06-03 | 1987-01-13 | Stolle Research & Development Corporation | Method for treating disorders of the vascular and pulmonary systems |
DE3378890D1 (en) * | 1983-06-07 | 1989-02-16 | Stolle Res & Dev | Deodorant containing bacterial antibodies |
JPS6112629A (ja) * | 1984-06-28 | 1986-01-21 | Lion Corp | 口腔内組成物 |
DE3785033T2 (de) * | 1987-07-21 | 1993-10-07 | Stolle Res & Dev | Verfahren zum Erhalten von immunregulierenden Faktoren mittels Säugetierimmunisierung. |
JP2664906B2 (ja) * | 1987-08-13 | 1997-10-22 | ストール・リサーチ・アンド・デイベロップメント・コーポレーション | 改良された哺乳類の免疫法 |
EP1171161A1 (en) * | 1999-04-19 | 2002-01-16 | Richard Weisbart | Treatment of adult rheumatoid arthritis by oral administration of pooled human immunoglobulin and an antacid |
CA2423805A1 (en) * | 2000-09-28 | 2002-04-04 | Richard Weisbart | Treatment of immune-mediated diseases by oral administration of plasma fractions enriched in immunoglobulin g |
PL214224B1 (pl) * | 2001-01-30 | 2013-07-31 | Lauridsen Group | Doustna forma koncentratu nie - hiperimmunizowanych nie-specyficznych immunoglobulin oraz suplement diety |
BR0206869A (pt) * | 2001-01-30 | 2007-01-02 | Lauridsen Group Inc | método para o tratamento de um animal sofrendo de um estado doentio de disfunção imune associado com nìveis alterados de igg ou tnf-delta, composição farmacêutica para o tratamento de distúrbios auto-imunes associados com elevados igg e/ou tnf-delta ou para a potenciação de protocolos de vacina, e método para o tratamento de estado doentio associado com disfunção imune em um animal |
JP4960632B2 (ja) * | 2006-01-10 | 2012-06-27 | 学校法人北里研究所 | 免疫ミルク組成物を有効成分とする単純ヘルペスウイルス感染症治療予防用組成物 |
JP5361132B2 (ja) * | 2006-03-10 | 2013-12-04 | 国立大学法人信州大学 | 免疫グロブリンgを含有する経口用免疫調節剤、その製造方法及び経口用免疫調節剤を配合してなる飲食品 |
JP2008179572A (ja) * | 2007-01-25 | 2008-08-07 | Shinshu Univ | 免疫グロブリンFcフラグメントレセプタータンパク及び/又は免疫グロブリンFcフラグメントレセプター様タンパク産生抑制剤及びその使用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH488013A (de) * | 1965-10-24 | 1970-03-31 | Immune Milk Company Of America | Verfahren zur Herstellung von Antitoxinen |
DE1617769A1 (de) * | 1967-06-10 | 1971-04-01 | Rehm Eberhard | Verfahren zur Gewinnung von spezifischen Antikoerper enthaltender Milch und daraus hergestellter Praeparate |
JPS5136326A (ja) * | 1974-09-24 | 1976-03-27 | Komatsu Seiren Co | Seikeigorufubooru |
JPS5837285B2 (ja) * | 1975-05-29 | 1983-08-15 | カブシキガイシヤ ミドリジユウジ | チヨウナイカンセンシヨウチリヨウザイノセイゾウホウホウ |
JPS521014A (en) * | 1975-06-17 | 1977-01-06 | Stolle Res & Dev | Pharmaceutically acceptable carrier containing milk immunoglobulin |
JPS5381613A (en) * | 1976-12-28 | 1978-07-19 | Green Cross Corp:The | Remedies for enteral infection diseases |
CH627079A5 (en) * | 1977-04-15 | 1981-12-31 | Nestle Sa | Process for preparing a protein concentrate containing immunological factors of milk origin |
-
1979
- 1979-01-30 SE SE7900798A patent/SE448344B/sv not_active IP Right Cessation
- 1979-01-31 NL NL7900766A patent/NL7900766A/xx not_active Application Discontinuation
- 1979-02-02 FR FR7902807A patent/FR2416015A1/fr active Granted
- 1979-02-02 GB GB7903836A patent/GB2013691B/en not_active Expired
- 1979-02-02 DE DE2904044A patent/DE2904044C2/de not_active Expired
- 1979-02-05 JP JP1215279A patent/JPS54113425A/ja active Granted
- 1979-02-05 IT IT47888/79A patent/IT1116524B/it active
- 1979-02-06 CH CH1168/79A patent/CH651210A5/de not_active IP Right Cessation
- 1979-02-06 DK DK049479A patent/DK158138C/da not_active IP Right Cessation
-
1983
- 1983-08-25 HK HK302/83A patent/HK30283A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE2904044A1 (de) | 1979-08-30 |
IT7947888A0 (it) | 1979-02-05 |
GB2013691B (en) | 1982-08-18 |
DE2904044C2 (de) | 1986-02-06 |
DK49479A (da) | 1979-08-07 |
NL7900766A (nl) | 1979-08-08 |
DK158138C (da) | 1990-08-27 |
SE7900798L (sv) | 1979-08-07 |
HK30283A (en) | 1983-09-02 |
GB2013691A (en) | 1979-08-15 |
FR2416015B1 (it) | 1983-06-17 |
JPS54113425A (en) | 1979-09-05 |
DK158138B (da) | 1990-04-02 |
FR2416015A1 (fr) | 1979-08-31 |
IT1116524B (it) | 1986-02-10 |
JPH0160455B2 (it) | 1989-12-22 |
CH651210A5 (de) | 1985-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4732757A (en) | Prevention and treatment of rheumatoid arthritis | |
SE448344B (sv) | Antikropp for behandling av reumatoid artrit samt sett att framstella denna | |
Liebhaber et al. | Alterations of lymphocytes and of antibody content of human milk after processing | |
US4324782A (en) | Dental caries inhibiting product of immunized cow's milk having antibodies specific to killed Streptococcus mutans cells | |
US20090258121A1 (en) | Method of producing nutritional products from human milk tissue and compositions thereof | |
Gabriel Michael et al. | The antimicrobial activity of human colostral antibody in the newborn | |
KR20000048855A (ko) | 닭의 난황 항체를 경구 투여하여 질병을 치료하는 방법 | |
Tawfeek et al. | Efficacy of an infant formula containing anti-Escherichia coli colostral antibodies from hyperimmunized cows in preventing diarrhea in infants and children: a field trial | |
Hammon | Staphylococcus enterotoxin: an improved cat test, chemical and immunological studies | |
KR890004019B1 (ko) | 요로 감염 치료용 백신의 제조방법 | |
USRE33565E (en) | Prevention and treatment of rheumatioid arthritis | |
Moodley et al. | The operculum syndrome: an unusual complication of tuberculous meningitis | |
Henderson et al. | Clinical problems: Subclinical Brucella infection in man | |
Newby et al. | The immune response of the pig following oral immunisation with soluble protein | |
Söderström et al. | Another Swedish family with complete properdin deficiency: association with fulminant meningococcal disease in one male family member | |
Dawson et al. | Immunological and Blood Products: Pharmaceutical Monographs | |
Nickerson et al. | Studies of immune and normal opsonins during experimental staphylococcal infection in rabbits | |
ROSEBURY | The Aerobic Non-hemolytic Streptococci: a Critical Review of their Characteristics and Pathogenicity with Special Reference to the Human Mouth and to Subacute Bacterial Endocarditis | |
Jones et al. | UDDER INFECTION WITH STREPTOCOCCI OF THE SCARLET FEVER TYPE: I. Spontaneous and Experimental Udder Infection. | |
Nathanson et al. | Cyclophosphamide-induced immunosuppression demonstrated in Pasteurella multocida-vaccinated chickens | |
Kohler et al. | Studies of Escherichia Coli in Gnotobiotic Pigs: II. The Immune Response | |
Eyre et al. | PROPHYLACTIC VACCINATIONS: AGAINST CATARRHAL AFFECTIONS OF THE RESPIRATORY TRACT | |
Cooper et al. | Immune responses of rats to live Vibrio cholerae: antibodies in serum and intestinal secretions | |
Cullor | Safety and efficacy of gram-negative bacterial vaccines | |
Rockwell et al. | Further studies on oral immunization to colds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 7900798-5 Format of ref document f/p: F |
|
NUG | Patent has lapsed |
Ref document number: 7900798-5 Format of ref document f/p: F |